| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 716089 | Null | 0.00479683626511385 | 0.32378793 |
| NSC 205555 | Butanoic acid, 2,3-dibromo-4-[(5-chloro-2-methoxyphenyl)amino]-4-oxo- | 0.00479683626511392 | 0.46902619 |
| NSC 641233 | 2-Naphthalenebutanamide, N-(3-chloro-1,4-dihydro- 1,4-dioxo-2-naphthalenyl)-.beta.-(1,3-dihydro-3-oxo- 1-isoindolyl)-.alpha.-,-.gamma.-dioxo- | 0.00479683626511392 | 0.57329306 |
| NSC 643813 | 3'-O-(Carboxymethyl)-(Z)-Combretastatin 4-A, Na salt, hydrate [1:1:2] | 0.00479683626511392 | 0.57768247 |
| NSC 643859 | Null | 0.00479683626511392 | 0.30725451 |
| NSC 652809 | Null | 0.00479683626511392 | 0.59927826 |
| NSC 658798 | Null | 0.00479683626511392 | 0.51181649 |
| NSC 668814 | 1-Oxa-4,7,10,13,16-pentaazacyclononadecane, cyclic peptide derivative | 0.00479683626511392 | -0.26342966 |
| NSC 104801 | Cytembena | 0.00645628049634952 | 0.43096277 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.00645628049634952 | 0.38994582 |